Innova Captab Limited (NSE:INNOVACAP)
1,088.50
+4.30 (0.40%)
Aug 21, 2026, 3:29 PM IST
Innova Captab Revenue
Innova Captab had revenue of 4.71B INR in the quarter ending June 30, 2026, with 33.94% growth. This brings the company's revenue in the last twelve months to 17.49B, up 34.47% year-over-year. In the fiscal year ending March 31, 2026, Innova Captab had annual revenue of 16.30B with 31.06% growth.
Revenue (ttm)
17.49B
Revenue Growth
+34.47%
P/S Ratio
3.56
Revenue / Employee
10.93M
Employees
1,600
Market Cap
62.29B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 16.30B | 3.86B | 31.06% |
| Mar 31, 2025 | 12.44B | 1.62B | 15.02% |
| Mar 31, 2024 | 10.81B | 1.55B | 16.72% |
| Mar 31, 2023 | 9.26B | 1.26B | 15.72% |
| Mar 31, 2022 | 8.01B | 3.90B | 94.94% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Strides Pharma Science | 50.04B |
| Akums Drugs and Pharmaceuticals | 45.04B |
| NATCO Pharma | 34.85B |
| Aarti Pharmalabs | 19.69B |
| Sun Pharma Advanced Research Company | 19.09B |
| Solara Active Pharma Sciences | 14.31B |
| Orchid Pharma | 8.43B |
| RPG Life Sciences | 7.34B |